ArticleCancer immunology, immunotherapy : CII2025

ARHGDIB as a prognostic biomarker and modulator of the immunosuppressive microenvironment in glioma.

Xuejun Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.